Subjects with biopsy-proven NAFLD (n=46) | Subjects with 1H-MRS-proven NAFLD (n=445) | |||
Fibrosis stage | P valve | NFS | P valve | |
Calcium | 0.111 | 0.507 | −0.193 | <0.001 |
Phosphate | 0.317 | 0.052 | −0.190 | <0.001 |
Magnesium | −0.083 | 0.619 | −0.125 | 0.016 |
PTH | −0.138 | 0.037 | 0.189 | <0.001 |
Osteocalcin | 0.155 | 0.353 | 0.117 | 0.024 |
25(OH)D | −0.065 | 0.697 | −0.138 | 0.008 |
β-CTX | 0.257 | 0.119 | 0.077 | 0.138 |
PINP | 0.305 | 0.062 | 0.114 | 0.028 |
BMI, body mass index; β-CTX, procollagen type I carboxy terminal peptide β special sequence; FPG, fasting plasma glucose; 1H-MRS, proton magnetic resonance spectrum; NAFLD, non-alcoholic fatty liver disease; NFS, NAFLD fibrosis score; 25(OH)D, 25-hydroxyvitamin D; PINP, procollagen type 1 N-terminal propeptide; PTH, parathyroid hormone.